What's in Onze Lieve Vrouwe Gasthuis's pipeline?

Onze Lieve Vrouwe Gasthuis has 6 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Onze Lieve Vrouwe Gasthuis's portfolio?

Top competitors by shared drug class: Aultman Health Foundation, Bristol-Myers Squibb, GF Strong Rehabilitation Centre, Instituto de Cardiologia de Santa Catarina, MediQuest Therapeutics.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/onze-lieve-vrouwe-gasthuis.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Onze Lieve Vrouwe Gasthuis — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Onze Lieve Vrouwe Gasthuis pipeline: 4 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
nadroparin	nadroparin	marketed			Cardiovascular
Infliximab-Innovator	Infliximab-Innovator	marketed
ISDN ointment	ISDN ointment	marketed	Nitrate vasodilator	Guanylate cyclase (via nitric oxide)	Cardiovascular
trisodium citrate	trisodium citrate	marketed	Anticoagulant / Alkalinizing agent	Ionized calcium (Ca2+)	Hematology / Nephrology

Therapeutic area mix

Cardiovascular · 2
Hematology / Nephrology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aultman Health Foundation · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
GF Strong Rehabilitation Centre · 1 shared drug class
Instituto de Cardiologia de Santa Catarina · 1 shared drug class
MediQuest Therapeutics · 1 shared drug class
Ohio State University · 1 shared drug class
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 1 shared drug class
Recep Tayyip Erdogan University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Onze Lieve Vrouwe Gasthuis:

Cite this brief

Drug Landscape (2026). Onze Lieve Vrouwe Gasthuis — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/onze-lieve-vrouwe-gasthuis. Accessed 2026-05-17.